# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-19-005256
Filing Date
2019-03-19
Accepted
2019-03-19 14:49:15
Documents
79
Period of Report
2018-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | dffn20181231_10k.htm | 10-K | 1702718
2 | EXHIBIT 3.1 | ex_137220.htm | EX-3.1 | 31986
3 | EXHIBIT 21.1 | ex_137086.htm | EX-21.1 | 5061
4 | EXHIBIT 23.1 | ex_137221.htm | EX-23.1 | 3542
5 | EXHIBIT 31.1 | ex_137083.htm | EX-31.1 | 15107
6 | EXHIBIT 31.2 | ex_137084.htm | EX-31.2 | 14428
7 | EXHIBIT 32.1 | ex_137085.htm | EX-32.1 | 5356
14 |  | kpmgsig.jpg | GRAPHIC | 2562
15 |  | dffn20181231_10kimg004.jpg | GRAPHIC | 28630
16 |  | dffn20181231_10kimg003.jpg | GRAPHIC | 9717
17 |  | dffn20181231_10kimg002.jpg | GRAPHIC | 14380
18 |  | chart02.jpg | GRAPHIC | 160392
| Complete submission text file | 0001437749-19-005256.txt |  | 6233613

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL INSTANCE DOCUMENT | dffn-20181231.xml | EX-101.INS | 901279
9 | XBRL TAXONOMY EXTENSION SCHEMA | dffn-20181231.xsd | EX-101.SCH | 58546
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | dffn-20181231_cal.xml | EX-101.CAL | 39664
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dffn-20181231_def.xml | EX-101.DEF | 417861
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dffn-20181231_lab.xml | EX-101.LAB | 364477
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dffn-20181231_pre.xml | EX-101.PRE | 447065

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 19691211
SIC: 2834 Pharmaceutical Preparations